Alphapharm slams Sanofi amendment delay in injunction battle

Christian Dimitriadis 2018-11-02 10:09 pm By Miklos Bolza | Sydney

Please login to bookmark

Generic drug maker Alphapharm says rival Sanofi-Aventis waited to amend its injector pen patent until the heated IP battle between the two firms had commenced, despite knowing about the amendments for three years.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au